Cargando…

Correction: Management of bleeding following major trauma: a European guideline

Detalles Bibliográficos
Autores principales:	Spahn, Donat R, Cerny, Vladimir, Coats, Timothy J, Duranteau, Jacques, Fernández-Mondéjar, Enrique, Gordini, Giovanni, Stahel, Philip F, Hunt, Beverley J, Komadina, Radko, Neugebauer, Edmund, Ozier, Yves, Riddez, Louis, Schultz, Arthur, Vincent, Jean-Louis, Rossaint, Rolf
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206476/ http://dx.doi.org/10.1186/cc5781

Ejemplares similares

Management of bleeding following major trauma: a European guideline
por: Spahn, Donat R, et al.
Publicado: (2007)

Management of bleeding following major trauma: an updated European guideline
por: Rossaint, Rolf, et al.
Publicado: (2010)

Management of bleeding and coagulopathy following major trauma: an updated European guideline
por: Spahn, Donat R, et al.
Publicado: (2013)

The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
por: Rossaint, Rolf, et al.
Publicado: (2016)

The STOP the Bleeding Campaign
por: Rossaint, Rolf, et al.
Publicado: (2013)

The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition
por: Spahn, Donat R., et al.
Publicado: (2019)

The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition
por: Rossaint, Rolf, et al.
Publicado: (2023)

Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective
por: Vincent, Jean-Louis, et al.
Publicado: (2006)

Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
por: Sørensen, Benny, et al.
Publicado: (2011)

Correction: Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
por: Sørensen, Benny, et al.
Publicado: (2011)

Epidemiology of firearm injuries in a Scandinavian trauma center
por: Bäckman, Pernilla Brandt, et al.
Publicado: (2018)

Clinical review is essential to evaluate 30-day mortality after trauma
por: Ghorbani, Poya, et al.
Publicado: (2014)

The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues
por: Zupan, Janja, et al.
Publicado: (2012)

Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
por: Klitgaard, Thomas, et al.
Publicado: (2006)

Digital rectal examination for initial assessment of the multi-injured patient: Can we depend on it?
por: Ahl, Rebecka, et al.
Publicado: (2016)

Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials
por: Rizoli, Sandro B, et al.
Publicado: (2006)

Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial
por: Roberts, Ian, et al.
Publicado: (2012)

Tranexamic acid: less bleeding and less thrombosis?
por: Godier, Anne, et al.
Publicado: (2012)

ADRA2A is involved in neuro-endocrine regulation of bone resorption
por: Mlakar, Vid, et al.
Publicado: (2015)

Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs
por: Honickel, M, et al.
Publicado: (2014)

Sex-determining region Y (SRY) attributes to gender differences in RANKL expression and incidence of osteoporosis
por: Kodrič, Klemen, et al.
Publicado: (2019)

Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
por: Rossaint, R, et al.
Publicado: (2006)

Blood substitutes
por: Spahn, Donat R
Publicado: (1999)

Blood substitutes Artificial oxygen carriers: perfluorocarbon emulsions
por: Spahn, Donat R
Publicado: (1999)

TEG®- or ROTEM®-based individualized goal-directed coagulation algorithms: don’t wait - act now!
por: Spahn, Donat R
Publicado: (2014)

Artificial oxygen carriers: a new future?
por: Spahn, Donat R.
Publicado: (2018)

Physicians’ perceptions regarding acute bleeding management: an international mixed qualitative quantitative study
por: Roche, Tadzio R., et al.
Publicado: (2021)

The desperate need for good-quality clinical trials to evaluate the optimal source and dose of fibrinogen in managing bleeding
por: Stanworth, Simon J, et al.
Publicado: (2011)

Comparison of two different coagulation algorithms on the use of allogenic blood products and coagulation factors in severely injured trauma patients: a retrospective, multicentre, observational study
por: Kaserer, Alexander, et al.
Publicado: (2018)

Comparison of the impact of applications of Targeted Transfusion Protocol and Massive Transfusion Protocol in trauma patients
por: Paydar, Shahram, et al.
Publicado: (2017)

Early identification of bleeding in trauma patients: external validation of traumatic bleeding scores in the Swiss Trauma Registry
por: Costa, Alan, et al.
Publicado: (2022)

Prevalence and outcome of contrast-induced nephropathy in major trauma patients
por: Kelemen, Julian Alexander, et al.
Publicado: (2020)

Impact of a goal-directed factor-based coagulation management on thromboembolic events following major trauma
por: Stein, Anais L., et al.
Publicado: (2019)

Blood management in intensive care medicine: CRIT and ABC – what can we learn?
por: Spahn, Donat R, et al.
Publicado: (2004)

Alternatives to blood transfusion
por: Spahn, Donat R, et al.
Publicado: (2013)

Not all anemia is solely due to iron deficiency
por: Rössler, Julian, et al.
Publicado: (2020)

Prehospital identification of trauma patients with early acute coagulopathy and massive bleeding: results of a prospective non-interventional clinical trial evaluating the Trauma Induced Coagulopathy Clinical Score (TICCS)
por: Tonglet, Martin L, et al.
Publicado: (2014)

Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model
por: Grottke, Oliver, et al.
Publicado: (2014)

Damage control strategy in bleeding trauma patients
por: Kim, Maru, et al.
Publicado: (2020)

Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia
por: Vincent, Jean-Louis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v2mpc3udpu7qubd4t4g5s134j0